Sanjeev Pandya of Advanced Oncotherapy (AVO) interviewed by BRR Media
Sanjeev Pandya, Executive Vice President for Global Business Development for Advanced Oncotherapy (AVO) provides an update to shareholders on development progress of the Company’s novel proton accelerator. Sanjeev also introduces Michel Baelen, the recently appointed Global Head of Regulatory Affairs. Click the image to watch.
Advanced Oncotherapy (AVO) – Directorate Change
Advanced Oncotherapy plc (AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that following the continued successful development of the Company’s first LIGHT system and the recent industrialisation agreement with Thales, the Board has decided to realign the roles and responsibilities of the Executive team to add additional focus to both operational […]
Advanced Oncotherapy announces the disposal of Oncotherapy Resources Ltd
Advanced Oncotherapy announces that it has disposed of its subsidiary, Oncotherapy Resources Ltd (“ORL”), for a total cash consideration of £100,000. An initial cash payment of £75,000 has been received with the remainder to be paid on the first anniversary of the disposal. ORL focuses on supplying a fully mobile managed service delivering electronic brachytherapy […]
Advanced Oncotherapy announces the successful high power testing of two Coupled Cavity Linac (CCL) modules
Advanced Oncotherapy announces that the high power testing of two Coupled Cavity Linac (CCL) modules at the Company’s facility in Geneva has been successfully completed. In August the Company announced that the two CCL modules were ready to be tested at high power and marked the first time two CCL modules were tested together. The modules have […]
Advanced Oncotherapy CEO discusses the second commercial sale of proton therapy system in China
Advanced Oncotherapy CEO Sanjeev Pandya discusses the second commercial sale of proton therapy system in China – BRR Media
Advanced Oncotherapy – Half year results
Advanced Oncotherapy announces unaudited results for the six months ended 30 June 2015. The Company remains on schedule in its technology development to have its LIGHT proton therapy system ready for patient treatment in London’s renowned Harley Street in 2017. The LIGHT system accelerates protons to the energy levels achieved in first-generation proton therapy machines but […]
Advanced Oncotherapy – CCL modules ready for high-power testing
Advanced Oncotherapy (AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that the two Coupled Cavity Linac modules are now ready for high-power testing at the Company’s facility in Geneva. These two modules will be tested at high power by using the Radio Frequency Power Units provided by ScandiNova and Toshiba and it is […]
Health Service Journal – Only together can we beat cancer
Collaboration between public and private organisations is vital if the NHS is to win the war on cancer, says Sanjeev Pandya, CEO of Advanced Oncotherapy (AVO). The government’s latest strategy to improve cancer treatment in the UK is welcome, but extra funding alone is not the answer. Greater collaboration is the key to winning the […]